May 25, 2021, Modiin, Israel.

Amotz Shemi, PhD, CEO of Silenseed will present in September 21-23, 2021 on: KRAS-LODER to Target Pancreatic Cancer: Ongoing Clinical Results from Phase 2

• LODER is a drug delivery product for regional delivery of RNAi-based drug

• KRAS-LODER shows encouraging clinical results in pancreatic cancer

• Utilization of KRAS-LODER to target NSCLC is in development

See page 4: